Appajosyula Sireesh — SEC Form 4 filings
SEC reporting owner CIK 1901565. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-08-12 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 6 filings — 3,326,496 shares, $270,369 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: purchase of 2,000,000 shares @ $0.05 ($100,000) in Hepion Pharmaceuticals, Inc., filed 2026-08-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | Chief Operating Officer, Director | 3 | 2 legs · 3,250,000 sh · $150,000 | — | 2 |
| Tharimmune, Inc. (THAR) | CEO, Director | 8 | 5 legs · 76,496 sh · $120,369 | — | 4 |
Form 4 filings — Appajosyula Sireesh
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Grant/award (A): 1,345,500 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 2,000,000 @ $0.05 · Purchase (P): 2,000,000 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Hepion Pharmaceuticals, Inc. (HEPA) | Purchase (P): 1,250,000 @ $0.04 | EDGAR |
| 2025-11-05 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-08-06 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Tharimmune, Inc. (THAR) | Purchase (P): 60,806 @ $1.48 · Purchase (P): 690 @ $1.42 | EDGAR |
| 2025-01-14 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 52,875 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Tharimmune, Inc. (THAR) | Purchase (P): 5,000 @ $2.02 | EDGAR |
| 2024-10-09 | 4/A | Tharimmune, Inc. (THAR) | Purchase (P): 5,000 @ $1.93 | EDGAR |
| 2024-10-08 | 4 | Tharimmune, Inc. (THAR) | Purchase (P): 5,000 @ $1.93 | EDGAR |
| 2024-08-12 | 4 | Tharimmune, Inc. (THAR) | Grant/award (A): 38,087 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1901565 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →